List of redirects
Jump to navigation
Jump to search
Showing below up to 50 results in range #8,721 to #8,770.
- CAPRIE → Clopidogrel Versus Aspirin In Patients At Risk Of Ischemic Events
- CAPS → The Cardiac Arrhythmic Pilot Study
- CAPT → Complications Of Amd (Age-Related Macular Degeneration) Prevention Trial
- CAPTEN → Captopril After Thrombolysis Trial
- CAPTIM → Comparison Of Angioplasty And Prehospital Thrombolysis In Acute Myocardial Infarction
- CAPTIN → Captopril Plus Tissue Plasminogen Activator Following Acute Myocardial Infarction
- CAPTIVATE → Carotid Atherosclerosis Progression Trial Investigating Vascular Acat Inhibition Treatment Effects
- CAPTIVE → A Prospective, Randomized, Controlled Trial Of Distal Protection With The Third Generation Mednova Emboshield Compared To The Guardwire Or Filterwire
- CAPTURE → Chimeric 7E3 Antiplatelet Therapy In Unstable Angina Refractory To Standard Treatment
- CAPTURE Registry → Carotid Acculink/Accunet Post-Approval Trial To Uncover Unanticipated Or Rare Events Registry
- CARAT → Coronary Angioplasty And Rotational Atherectomy Trial
- CARD15 → NOD2
- CARDENE I.V. adverse reactions → Nicardipine#Adverse Reactions
- CARDENE I.V. clinical pharmacology → Nicardipine#Pharmacology
- CARDENE I.V. clinical studies → Nicardipine#Clinical Studies
- CARDENE I.V. contraindications → Nicardipine#Contraindications
- CARDENE I.V. description → Nicardipine#Structure
- CARDENE I.V. dosage and administration → Nicardipine#Adult Indications and Dosage
- CARDENE I.V. dosage forms and strengths → Nicardipine#How Supplied
- CARDENE I.V. drug interactions → Nicardipine#Drug Interactions
- CARDENE I.V. how supplied storage and handling → Nicardipine#How Supplied
- CARDENE I.V. indications and usage → Nicardipine#Adult Indications and Dosage
- CARDENE I.V. labels and packaging → Nicardipine#Package and Label Display Panel
- CARDENE I.V. nonclinical toxicology → Nicardipine#Nonclinical Toxicology
- CARDENE I.V. overdosage → Nicardipine#Overdosage
- CARDENE I.V. use in specific populations → Nicardipine#Use in Specific Populations
- CARDENE I.V. warnings and precautions → Nicardipine#Warnings
- CARDENE SR adverse reactions → Nicardipine#Adverse Reactions
- CARDENE SR clinical pharmacology → Nicardipine#Pharmacology
- CARDENE SR contraindications → Nicardipine#Contraindications
- CARDENE SR description → Nicardipine#Structure
- CARDENE SR dosage and administration → Nicardipine#Adult Indications and Dosage
- CARDENE SR drug interactions → Nicardipine#Drug Interactions
- CARDENE SR how supplied storage and handling → Nicardipine#How Supplied
- CARDENE SR indications and usage → Nicardipine#Adult Indications and Dosage
- CARDENE SR labels and packaging → Nicardipine#Package and Label Display Panel
- CARDENE SR nonclinical toxicology → Nicardipine#Nonclinical Toxicology
- CARDENE SR overdosage → Nicardipine#Overdosage
- CARDENE SR use in specific populations → Nicardipine#Use in Specific Populations
- CARDENE SR warnings and precautions → Nicardipine#Warnings
- CARDIA → Coronary Artery Risk Development In Young Adults
- CARDIAC ARREST → Sudden cardiac death
- CARDINAL → Complement And Reduction Of Infarct Size After Angioplasty Or Lytics
- CARDIOVASCULAR → Circulatory system
- CARDS Trial → CARDS
- CARDia → Coronary Artery Revascularization In Diabetes Trial
- CARE-HD → Coenzyme Q10 And Remacemide: Evaluation In Huntington Disease
- CARE-HF → Cardiac Resynchronization - Heart Failure European Complement To U.S./Canada Miracle Study
- CARESS → Clopidogrel And Aspirin For Reduction Of Emboli In Symptomatic Carotid Stenosis
- CARESS-in-AMI: 30-Day and 1-Year Results → Combined Abciximab Reteplase Stent Study In Acute Myocardial Infarction: 30-Day and 1-Year Results